Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
stem cell harvest
BIOLOGICAL
2 trials
Sponsors
European Mantle Cell Lymphoma Network
, Post Graduate Institute of Medical Education and Research, Chandigarh
Conditions
Lymphoma, Mantle-Cell
Type 2 Diabetes Mellitus
Phase 2
Efficacy Of Autologous Bone Marrow Derived Stem Cell Transplantation In Patients With Type 2 Diabetes Mellitus
Completed
NCT00644241
Post Graduate Institute of Medical Education and Research, Chandigarh
Type 2 Diabetes Mellitus
Start: 2008-01-31
End: 2009-06-30
Updated: 2015-10-21
Phase 3
Efficacy of R-CHOP vs R-CHOP/R-DHAP in Untreated MCL
NCT00209222
European Mantle Cell Lymphoma Network
Lymphoma, Mantle-Cell
Start: 2004-07-31
End: 2014-12-31
Target: 360
Updated: 2012-09-10
Related Papers
Aberrant Cytoplasmic Expression of p16 Is a New Strong Prognostic Marker in Young MCL Patients Treated By Frontline Cytarabine-Based Immunochemotherapy, a Study from the Lysa Group, Nordic Lymphoma Group and the European MCL Network
Blood
2024-11-05
<i>Intensified Immunochemotherapy with Autologous Stem Cell Transplantation for Mantle Cell Lymphoma - Could It Still be Considered the Standard of Care?</i>
Blood
2024-11-05
Validation of POD24 As a Robust Early Clinical End Point of Poor Survival in Mantle Cell Lymphoma from 1280 Patients on Clinical Trials
Blood
2023-11-02
9 citations
A Clinical Prognostic Model Based on Machine Learning from the Fondazione Italiana Linfomi (FIL) MCL0208 Phase III Trial
Cancers
2021-12-31
13 citations
Addition of high-dose cytarabine to immunochemotherapy before autologous stem-cell transplantation in patients aged 65 years or younger with mantle cell lymphoma (MCL Younger): a randomised, open-label, phase 3 trial of the European Mantle Cell Lymphoma Network.
2016-06-14
280 citations
High-dose cytarabine does not overcome the adverse prognostic value of CDKN2A and TP53 deletions in mantle cell lymphoma
Blood
2015-05-29
154 citations
Molecular remission is an independent predictor of clinical outcome in patients with mantle cell lymphoma after combined immunochemotherapy: a European MCL intergroup study.
2009-12-23
207 citations